Cerity Partners’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Cerity Partners's BCAT Position: Q1 2026 in Review
Cerity Partners sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q1 2026, closing a stake of 46,632 shares — an estimated $660K sold.
Cerity Partners first reported a position in BCAT in Q4 2022 and held it in 13 quarters. The position peaked at $666K in Q1 2024. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- Cerity Partners reported no remaining BlackRock Capital Allocation Term Trust position as of Q1 2026 after selling out during the quarter.
- Cerity Partners sold 46,632 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $660K.
- Cerity Partners first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and held it in 13 quarters.
- Cerity Partners's BlackRock Capital Allocation Term Trust position peaked at $666K in Q1 2024.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.